Carl Counsell Selected Research

Carl Counsell Research Topics

7	Ischemic Stroke 03/2015 - 07/2002
6	Stroke (Strokes) 03/2015 - 04/2002
3	Chronic Progressive Multiple Sclerosis 01/2021 - 01/2017
3	Venous Thrombosis (Deep-Vein Thrombosis) 03/2015 - 07/2008
3	Pulmonary Embolism 03/2015 - 07/2008
3	Parkinson Disease (Parkinson's Disease) 12/2013 - 09/2004
2	Status Epilepticus (Complex Partial Status Epilepticus) 07/2022 - 01/2022
2	Disease Progression 01/2020 - 10/2009
2	Relapsing-Remitting Multiple Sclerosis 10/2018 - 01/2017
2	Hemorrhage 03/2015 - 10/2008
2	Embolism (Embolus) 03/2014 - 07/2008
1	Neurobehavioral Manifestations 08/2022
1	Dementia (Dementias) 08/2022
1	Seizures (Absence Seizure) 01/2022
1	Multiple Sclerosis 01/2017
1	Torticollis (Wryneck) 02/2016
1	Cognitive Dysfunction 12/2013
1	Parkinsonian Disorders (Parkinsonism) 05/2013

2	Midazolam (Versed)FDA LinkGeneric 07/2022 - 01/2022
2	Diazepam (Valium)FDA LinkGeneric 07/2022 - 01/2022
2	BenzodiazepinesIBA 07/2022 - 01/2022
2	ocrelizumabIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 05/2013
2	Glatiramer Acetate (Copaxone)FDA Link 10/2018 - 01/2017
2	AnticoagulantsIBA 03/2015 - 10/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2014 - 07/2008
2	Monoamine Oxidase (MAO)IBA 10/2009 - 09/2004
2	Heparinoids (Heparinoid)IBA 07/2008 - 07/2002
2	Heparin (Liquaemin)FDA LinkGeneric 07/2008 - 07/2002
1	Apolipoproteins E (ApoE)IBA 08/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Lorazepam (Ativan)FDA LinkGeneric 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	InterferonsIBA 10/2018
1	Interferon-betaIBA 01/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 02/2016
1	Matrix Metalloproteinases (MMPs)IBA 12/2013
1	Fibrinogen (Factor I)FDA Link 03/2012
1	Dopamine Agents (Dopaminergic Agents)IBA 10/2009
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2008

6	Therapeutics 01/2020 - 07/2008
1	Institutionalization (Institutionalized Persons) 08/2022
1	Injections 02/2016
1	Activities of Daily Living (ADL) 04/2002